Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition

Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors

(2013) Helene Henon et al.   Anti-Cancer Agents in Medicinal Chemistry

Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor

(2009) Ruchi Anand et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles

(2008) Elisabeth Conchon et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Extremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3

(2008) G. Ekin Atilla-Gokcumen et al.   CHEMBIOCHEM

A quantitative analysis of kinase inhibitor selectivity

(2008) Mazen W Karaman et al.   NATURE BIOTECHNOLOGY

Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of pyrrolo[3,4-a]carbazole-1,3-diones, pyrrolo[3,4-c]carbazole-1,3-diones, and 2-aminopyridazino[3,4-a]pyrrolo[3,4-c]carbazole-1,3,4,7-tetraone

(2007) Elisabeth Conchon et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY